Mounjaro Joins China's National Health Insurance: A Game Changer for Diabetes Treatment

Mounjaro, Eli Lillys diabetes drug, gains national health insurance coverage in China, expanding access to millions. Ozempic, Novo Nordisks rival, already on the list, saw significant sales. Mounjaros price under Chinas reimbursement plan remains undisclosed, but sales have been strong.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.